The global Organ Transplant Immunosuppressant Drugs market was valued at US$ 5102 million in 2023 and is anticipated to reach US$ 6403.3 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.

Organ Transplant Immunosuppressant Drugs Market

Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Organ Transplant Immunosuppressant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Transplant Immunosuppressant Drugs.

Report Scope

The Organ Transplant Immunosuppressant Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Organ Transplant Immunosuppressant Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Organ Transplant Immunosuppressant Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Organ Transplant Immunosuppressant Drugs Market Report

Report Metric	Details
Report Name	Organ Transplant Immunosuppressant Drugs Market
Accounted market size in 2023	US$ 5102 million
Forecasted market size in 2030	US$ 6403.3 million
CAGR	3.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Antibodies Antiproliferative Agents Calcineurin Inhibitors mTOR Inhibitors Steroids
Segment by Application	Bone Marrow Transplant Heart Transplant Kidney Transplant Liver Transplant Lung Transplant
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche, Sanofi, Astellas Pharma, Inc., GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Veloxis Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Organ Transplant Immunosuppressant Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Organ Transplant Immunosuppressant Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Organ Transplant Immunosuppressant Drugs Market growing?

Ans: The Organ Transplant Immunosuppressant Drugs Market witnessing a CAGR of 3.2% during the forecast period 2024-2030.

What is the Organ Transplant Immunosuppressant Drugs Market size in 2030?

Ans: The Organ Transplant Immunosuppressant Drugs Market size in 2030 will be US$ 6403.3 million.

Who are the main players in the Organ Transplant Immunosuppressant Drugs Market report?

Ans: The main players in the Organ Transplant Immunosuppressant Drugs Market are Roche, Sanofi, Astellas Pharma, Inc., GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Veloxis Pharmaceuticals

What are the Application segmentation covered in the Organ Transplant Immunosuppressant Drugs Market report?

Ans: The Applications covered in the Organ Transplant Immunosuppressant Drugs Market report are Bone Marrow Transplant, Heart Transplant, Kidney Transplant, Liver Transplant, Lung Transplant

What are the Type segmentation covered in the Organ Transplant Immunosuppressant Drugs Market report?

Ans: The Types covered in the Organ Transplant Immunosuppressant Drugs Market report are Antibodies, Antiproliferative Agents, Calcineurin Inhibitors, mTOR Inhibitors, Steroids

1 Organ Transplant Immunosuppressant Drugs Market Overview

1.1 Product Overview and Scope of Organ Transplant Immunosuppressant Drugs

1.2 Organ Transplant Immunosuppressant Drugs Segment by Type

1.2.1 Global Organ Transplant Immunosuppressant Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Antibodies

1.2.3 Antiproliferative Agents

1.2.4 Calcineurin Inhibitors

1.2.5 mTOR Inhibitors

1.2.6 Steroids

1.3 Organ Transplant Immunosuppressant Drugs Segment by Application

1.3.1 Global Organ Transplant Immunosuppressant Drugs Market Value by Application: (2024-2030)

1.3.2 Bone Marrow Transplant

1.3.3 Heart Transplant

1.3.4 Kidney Transplant

1.3.5 Liver Transplant

1.3.6 Lung Transplant

1.4 Global Organ Transplant Immunosuppressant Drugs Market Size Estimates and Forecasts

1.4.1 Global Organ Transplant Immunosuppressant Drugs Revenue 2019-2030

1.4.2 Global Organ Transplant Immunosuppressant Drugs Sales 2019-2030

1.4.3 Global Organ Transplant Immunosuppressant Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Organ Transplant Immunosuppressant Drugs Market Competition by Manufacturers

2.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Organ Transplant Immunosuppressant Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Organ Transplant Immunosuppressant Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Organ Transplant Immunosuppressant Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Organ Transplant Immunosuppressant Drugs, Product Type & Application

2.7 Organ Transplant Immunosuppressant Drugs Market Competitive Situation and Trends

2.7.1 Organ Transplant Immunosuppressant Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Organ Transplant Immunosuppressant Drugs Players Market Share by Revenue

2.7.3 Global Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Organ Transplant Immunosuppressant Drugs Retrospective Market Scenario by Region

3.1 Global Organ Transplant Immunosuppressant Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Organ Transplant Immunosuppressant Drugs Global Organ Transplant Immunosuppressant Drugs Sales by Region: 2019-2030

3.2.1 Global Organ Transplant Immunosuppressant Drugs Sales by Region: 2019-2024

3.2.2 Global Organ Transplant Immunosuppressant Drugs Sales by Region: 2025-2030

3.3 Global Organ Transplant Immunosuppressant Drugs Global Organ Transplant Immunosuppressant Drugs Revenue by Region: 2019-2030

3.3.1 Global Organ Transplant Immunosuppressant Drugs Revenue by Region: 2019-2024

3.3.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Region: 2025-2030

3.4 North America Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country

3.4.1 North America Organ Transplant Immunosuppressant Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2030)

3.4.3 North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country

3.5.1 Europe Organ Transplant Immunosuppressant Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2030)

3.5.3 Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country

3.7.1 Latin America Organ Transplant Immunosuppressant Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2030)

3.7.3 Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Organ Transplant Immunosuppressant Drugs Sales by Type (2019-2030)

4.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Type (2019-2024)

4.1.2 Global Organ Transplant Immunosuppressant Drugs Sales by Type (2025-2030)

4.1.3 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2019-2030)

4.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2019-2030)

4.2.1 Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2019-2024)

4.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2025-2030)

4.2.3 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Organ Transplant Immunosuppressant Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Organ Transplant Immunosuppressant Drugs Sales by Application (2019-2030)

5.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Application (2019-2024)

5.1.2 Global Organ Transplant Immunosuppressant Drugs Sales by Application (2025-2030)

5.1.3 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2019-2030)

5.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2019-2030)

5.2.1 Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2019-2024)

5.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2025-2030)

5.2.3 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Organ Transplant Immunosuppressant Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Corporation Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Roche Organ Transplant Immunosuppressant Drugs Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Sanofi

6.2.1 Sanofi Corporation Information

6.2.2 Sanofi Description and Business Overview

6.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Sanofi Organ Transplant Immunosuppressant Drugs Product Portfolio

6.2.5 Sanofi Recent Developments/Updates

6.3 Astellas Pharma, Inc.

6.3.1 Astellas Pharma, Inc. Corporation Information

6.3.2 Astellas Pharma, Inc. Description and Business Overview

6.3.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product Portfolio

6.3.5 Astellas Pharma, Inc. Recent Developments/Updates

6.4 GlaxoSmithKline plc

6.4.1 GlaxoSmithKline plc Corporation Information

6.4.2 GlaxoSmithKline plc Description and Business Overview

6.4.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product Portfolio

6.4.5 GlaxoSmithKline plc Recent Developments/Updates

6.5 Novartis AG

6.5.1 Novartis AG Corporation Information

6.5.2 Novartis AG Description and Business Overview

6.5.3 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Novartis AG Organ Transplant Immunosuppressant Drugs Product Portfolio

6.5.5 Novartis AG Recent Developments/Updates

6.6 Pfizer, Inc.

6.6.1 Pfizer, Inc. Corporation Information

6.6.2 Pfizer, Inc. Description and Business Overview

6.6.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product Portfolio

6.6.5 Pfizer, Inc. Recent Developments/Updates

6.7 Veloxis Pharmaceuticals

6.6.1 Veloxis Pharmaceuticals Corporation Information

6.6.2 Veloxis Pharmaceuticals Description and Business Overview

6.6.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product Portfolio

6.7.5 Veloxis Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Organ Transplant Immunosuppressant Drugs Industry Chain Analysis

7.2 Organ Transplant Immunosuppressant Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Organ Transplant Immunosuppressant Drugs Production Mode & Process

7.4 Organ Transplant Immunosuppressant Drugs Sales and Marketing

7.4.1 Organ Transplant Immunosuppressant Drugs Sales Channels

7.4.2 Organ Transplant Immunosuppressant Drugs Distributors

7.5 Organ Transplant Immunosuppressant Drugs Customers

8 Organ Transplant Immunosuppressant Drugs Market Dynamics

8.1 Organ Transplant Immunosuppressant Drugs Industry Trends

8.2 Organ Transplant Immunosuppressant Drugs Market Drivers

8.3 Organ Transplant Immunosuppressant Drugs Market Challenges

8.4 Organ Transplant Immunosuppressant Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Veloxis Pharmaceuticals

Roche

List of Tables

Table 1. Global Organ Transplant Immunosuppressant Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Organ Transplant Immunosuppressant Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Organ Transplant Immunosuppressant Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Organ Transplant Immunosuppressant Drugs Average Price (USD/ Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Organ Transplant Immunosuppressant Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Organ Transplant Immunosuppressant Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Organ Transplant Immunosuppressant Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Organ Transplant Immunosuppressant Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Organ Transplant Immunosuppressant Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppressant Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Organ Transplant Immunosuppressant Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Organ Transplant Immunosuppressant Drugs Sales by Region (2019-2024) & (K Doses)

Table 18. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Organ Transplant Immunosuppressant Drugs Sales by Region (2025-2030) & (K Doses)

Table 20. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Organ Transplant Immunosuppressant Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Organ Transplant Immunosuppressant Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Organ Transplant Immunosuppressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2024) & (K Doses)

Table 27. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2025-2030) & (K Doses)

Table 28. North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Organ Transplant Immunosuppressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2024) & (K Doses)

Table 32. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2025-2030) & (K Doses)

Table 33. Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2019-2024)

Table 51. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2025-2030)

Table 52. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Type (2019-2024)

Table 59. Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Type (2025-2030)

Table 60. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2019-2024)

Table 61. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2025-2030)

Table 62. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Application (2019-2024)

Table 69. Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Application (2025-2030)

Table 70. Roche Corporation Information

Table 71. Roche Description and Business Overview

Table 72. Roche Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2019-2024)

Table 73. Roche Organ Transplant Immunosuppressant Drugs Product

Table 74. Roche Recent Developments/Updates

Table 75. Sanofi Corporation Information

Table 76. Sanofi Description and Business Overview

Table 77. Sanofi Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2019-2024)

Table 78. Sanofi Organ Transplant Immunosuppressant Drugs Product

Table 79. Sanofi Recent Developments/Updates

Table 80. Astellas Pharma, Inc. Corporation Information

Table 81. Astellas Pharma, Inc. Description and Business Overview

Table 82. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2019-2024)

Table 83. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product

Table 84. Astellas Pharma, Inc. Recent Developments/Updates

Table 85. GlaxoSmithKline plc Corporation Information

Table 86. GlaxoSmithKline plc Description and Business Overview

Table 87. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2019-2024)

Table 88. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product

Table 89. GlaxoSmithKline plc Recent Developments/Updates

Table 90. Novartis AG Corporation Information

Table 91. Novartis AG Description and Business Overview

Table 92. Novartis AG Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2019-2024)

Table 93. Novartis AG Organ Transplant Immunosuppressant Drugs Product

Table 94. Novartis AG Recent Developments/Updates

Table 95. Pfizer, Inc. Corporation Information

Table 96. Pfizer, Inc. Description and Business Overview

Table 97. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2019-2024)

Table 98. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product

Table 99. Pfizer, Inc. Recent Developments/Updates

Table 100. Veloxis Pharmaceuticals Corporation Information

Table 101. Veloxis Pharmaceuticals Description and Business Overview

Table 102. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2019-2024)

Table 103. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product

Table 104. Veloxis Pharmaceuticals Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Organ Transplant Immunosuppressant Drugs Distributors List

Table 108. Organ Transplant Immunosuppressant Drugs Customers List

Table 109. Organ Transplant Immunosuppressant Drugs Market Trends

Table 110. Organ Transplant Immunosuppressant Drugs Market Drivers

Table 111. Organ Transplant Immunosuppressant Drugs Market Challenges

Table 112. Organ Transplant Immunosuppressant Drugs Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Organ Transplant Immunosuppressant Drugs

Figure 2. Global Organ Transplant Immunosuppressant Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Organ Transplant Immunosuppressant Drugs Market Share by Type in 2023 & 2030

Figure 4. Antibodies Product Picture

Figure 5. Antiproliferative Agents Product Picture

Figure 6. Calcineurin Inhibitors Product Picture

Figure 7. mTOR Inhibitors Product Picture

Figure 8. Steroids Product Picture

Figure 9. Global Organ Transplant Immunosuppressant Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Organ Transplant Immunosuppressant Drugs Market Share by Application in 2023 & 2030

Figure 11. Bone Marrow Transplant

Figure 12. Heart Transplant

Figure 13. Kidney Transplant

Figure 14. Liver Transplant

Figure 15. Lung Transplant

Figure 16. Global Organ Transplant Immunosuppressant Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Organ Transplant Immunosuppressant Drugs Market Size (2019-2030) & (US$ Million)

Figure 18. Global Organ Transplant Immunosuppressant Drugs Sales (2019-2030) & (K Doses)

Figure 19. Global Organ Transplant Immunosuppressant Drugs Average Price (USD/ Dose) & (2019-2030)

Figure 20. Organ Transplant Immunosuppressant Drugs Report Years Considered

Figure 21. Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers in 2023

Figure 22. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers in 2023

Figure 23. The Global 5 and 10 Largest Organ Transplant Immunosuppressant Drugs Players: Market Share by Revenue in 2023

Figure 24. Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 25. Global Organ Transplant Immunosuppressant Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 26. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2019-2030)

Figure 27. North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2019-2030)

Figure 28. U.S. Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Canada Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2019-2030)

Figure 31. Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2019-2030)

Figure 32. Germany Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. France Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. U.K. Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Italy Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Russia Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2019-2030)

Figure 38. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2019-2030)

Figure 39. China Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Japan Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. South Korea Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. India Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Australia Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Taiwan Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Indonesia Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Thailand Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Malaysia Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Philippines Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2019-2030)

Figure 50. Latin America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2019-2030)

Figure 51. Mexico Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Brazil Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Argentina Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2019-2030)

Figure 55. Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2019-2030)

Figure 56. Turkey Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. U.A.E Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Global Sales Market Share of Organ Transplant Immunosuppressant Drugs by Type (2019-2030)

Figure 60. Global Revenue Market Share of Organ Transplant Immunosuppressant Drugs by Type (2019-2030)

Figure 61. Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Type (2019-2030)

Figure 62. Global Sales Market Share of Organ Transplant Immunosuppressant Drugs by Application (2019-2030)

Figure 63. Global Revenue Market Share of Organ Transplant Immunosuppressant Drugs by Application (2019-2030)

Figure 64. Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Application (2019-2030)

Figure 65. Organ Transplant Immunosuppressant Drugs Value Chain

Figure 66. Organ Transplant Immunosuppressant Drugs Production Process

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Distributors Profiles

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions